Spironolactone, but not enalapril, potentiates hypoxia-inducible factor-1α and ets-1 expression in newborn rat kidney

Hyung-Eun Yim, J. H. Kim, Kee Hwan Yoo, I. S. Bae, Giyoung Jang, Young Sook Hong, J. W. Lee

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Hypoxia is regarded as an important physiological factor that controls nephrogenesis. We investigated whether the reninangiotensin-aldosterone system (RAAS) affects hypoxia-related target genes in developing kidneys. Newborn rat pups were treated with enalapril (30 mg/kg/d) or spironolactone (200 mg/kg/d) for 7 days. Tissue hypoxia was assessed by the uptake of a hypoxyprobe-1, pimonidazole (200 mg/kg), and the expression of hypoxia-responsive genes. In the enalapril group, hypoxia-inducible factor (HIF)-1α, HIF-2α, and Ets-1 protein expression were not changed, compared to the control group. In the spironolactone group, HIF-1α and Ets-1 protein expression were significantly increased by immunoblots and immunohistochemistry, whereas HIF-2α protein expression was not changed, compared to the control group. In the enalapril group, the immunoactivity of pimonidazole was not significantly different from that of the controls. However, in the spironolactone group, pimonidazole staining demonstrated that the cortex and medulla underwent severe hypoxia. In summary, our data showed that aldosterone inhibition in the developing kidney augmented the hypoxic responses, and up-regulated the expression of key mediators of hypoxia including HIF-1α and Ets-1. Angiotensin II inhibition did not affect hypoxia-related alterations in the developing kidney. The components of RAAS may differentially modulate renal hypoxia and its related target genes in the developing rat kidney.

Original languageEnglish
Pages (from-to)74-81
Number of pages8
JournalJournal of Physiology and Pharmacology
Volume61
Issue number1
Publication statusPublished - 2010 Feb 1

Fingerprint

Hypoxia-Inducible Factor 1
Spironolactone
Enalapril
Kidney
Aldosterone
Genes
Control Groups
Proteins
Hypoxia
Angiotensin II
Immunohistochemistry
Staining and Labeling
pimonidazole

Keywords

  • Aldosterone
  • Angiotensin
  • Angiotensin converting enzyme
  • Hypoxia
  • Hypoxia-inducible factor
  • Kidney development

ASJC Scopus subject areas

  • Physiology
  • Pharmacology

Cite this

Spironolactone, but not enalapril, potentiates hypoxia-inducible factor-1α and ets-1 expression in newborn rat kidney. / Yim, Hyung-Eun; Kim, J. H.; Yoo, Kee Hwan; Bae, I. S.; Jang, Giyoung; Hong, Young Sook; Lee, J. W.

In: Journal of Physiology and Pharmacology, Vol. 61, No. 1, 01.02.2010, p. 74-81.

Research output: Contribution to journalArticle

@article{18760995ee764629a0213c18a737c999,
title = "Spironolactone, but not enalapril, potentiates hypoxia-inducible factor-1α and ets-1 expression in newborn rat kidney",
abstract = "Hypoxia is regarded as an important physiological factor that controls nephrogenesis. We investigated whether the reninangiotensin-aldosterone system (RAAS) affects hypoxia-related target genes in developing kidneys. Newborn rat pups were treated with enalapril (30 mg/kg/d) or spironolactone (200 mg/kg/d) for 7 days. Tissue hypoxia was assessed by the uptake of a hypoxyprobe-1, pimonidazole (200 mg/kg), and the expression of hypoxia-responsive genes. In the enalapril group, hypoxia-inducible factor (HIF)-1α, HIF-2α, and Ets-1 protein expression were not changed, compared to the control group. In the spironolactone group, HIF-1α and Ets-1 protein expression were significantly increased by immunoblots and immunohistochemistry, whereas HIF-2α protein expression was not changed, compared to the control group. In the enalapril group, the immunoactivity of pimonidazole was not significantly different from that of the controls. However, in the spironolactone group, pimonidazole staining demonstrated that the cortex and medulla underwent severe hypoxia. In summary, our data showed that aldosterone inhibition in the developing kidney augmented the hypoxic responses, and up-regulated the expression of key mediators of hypoxia including HIF-1α and Ets-1. Angiotensin II inhibition did not affect hypoxia-related alterations in the developing kidney. The components of RAAS may differentially modulate renal hypoxia and its related target genes in the developing rat kidney.",
keywords = "Aldosterone, Angiotensin, Angiotensin converting enzyme, Hypoxia, Hypoxia-inducible factor, Kidney development",
author = "Hyung-Eun Yim and Kim, {J. H.} and Yoo, {Kee Hwan} and Bae, {I. S.} and Giyoung Jang and Hong, {Young Sook} and Lee, {J. W.}",
year = "2010",
month = "2",
day = "1",
language = "English",
volume = "61",
pages = "74--81",
journal = "Journal of Physiology and Pharmacology",
issn = "0867-5910",
publisher = "Polish Physiological Society",
number = "1",

}

TY - JOUR

T1 - Spironolactone, but not enalapril, potentiates hypoxia-inducible factor-1α and ets-1 expression in newborn rat kidney

AU - Yim, Hyung-Eun

AU - Kim, J. H.

AU - Yoo, Kee Hwan

AU - Bae, I. S.

AU - Jang, Giyoung

AU - Hong, Young Sook

AU - Lee, J. W.

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Hypoxia is regarded as an important physiological factor that controls nephrogenesis. We investigated whether the reninangiotensin-aldosterone system (RAAS) affects hypoxia-related target genes in developing kidneys. Newborn rat pups were treated with enalapril (30 mg/kg/d) or spironolactone (200 mg/kg/d) for 7 days. Tissue hypoxia was assessed by the uptake of a hypoxyprobe-1, pimonidazole (200 mg/kg), and the expression of hypoxia-responsive genes. In the enalapril group, hypoxia-inducible factor (HIF)-1α, HIF-2α, and Ets-1 protein expression were not changed, compared to the control group. In the spironolactone group, HIF-1α and Ets-1 protein expression were significantly increased by immunoblots and immunohistochemistry, whereas HIF-2α protein expression was not changed, compared to the control group. In the enalapril group, the immunoactivity of pimonidazole was not significantly different from that of the controls. However, in the spironolactone group, pimonidazole staining demonstrated that the cortex and medulla underwent severe hypoxia. In summary, our data showed that aldosterone inhibition in the developing kidney augmented the hypoxic responses, and up-regulated the expression of key mediators of hypoxia including HIF-1α and Ets-1. Angiotensin II inhibition did not affect hypoxia-related alterations in the developing kidney. The components of RAAS may differentially modulate renal hypoxia and its related target genes in the developing rat kidney.

AB - Hypoxia is regarded as an important physiological factor that controls nephrogenesis. We investigated whether the reninangiotensin-aldosterone system (RAAS) affects hypoxia-related target genes in developing kidneys. Newborn rat pups were treated with enalapril (30 mg/kg/d) or spironolactone (200 mg/kg/d) for 7 days. Tissue hypoxia was assessed by the uptake of a hypoxyprobe-1, pimonidazole (200 mg/kg), and the expression of hypoxia-responsive genes. In the enalapril group, hypoxia-inducible factor (HIF)-1α, HIF-2α, and Ets-1 protein expression were not changed, compared to the control group. In the spironolactone group, HIF-1α and Ets-1 protein expression were significantly increased by immunoblots and immunohistochemistry, whereas HIF-2α protein expression was not changed, compared to the control group. In the enalapril group, the immunoactivity of pimonidazole was not significantly different from that of the controls. However, in the spironolactone group, pimonidazole staining demonstrated that the cortex and medulla underwent severe hypoxia. In summary, our data showed that aldosterone inhibition in the developing kidney augmented the hypoxic responses, and up-regulated the expression of key mediators of hypoxia including HIF-1α and Ets-1. Angiotensin II inhibition did not affect hypoxia-related alterations in the developing kidney. The components of RAAS may differentially modulate renal hypoxia and its related target genes in the developing rat kidney.

KW - Aldosterone

KW - Angiotensin

KW - Angiotensin converting enzyme

KW - Hypoxia

KW - Hypoxia-inducible factor

KW - Kidney development

UR - http://www.scopus.com/inward/record.url?scp=77954257849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954257849&partnerID=8YFLogxK

M3 - Article

C2 - 20228418

AN - SCOPUS:77954257849

VL - 61

SP - 74

EP - 81

JO - Journal of Physiology and Pharmacology

JF - Journal of Physiology and Pharmacology

SN - 0867-5910

IS - 1

ER -